Mitsubishi Chemical Group Corporation [4188.T]
TOKYO, Apr 22 (Pulse News Wire) – Mitsubishi Chemical Group Corporation (4188.T) decided to revise its investment plan for ethylene-vinyl alcohol copolymer resin “Soarnol™” produced by its subsidiary Mitsubishi Chemical UK Limited. Due to delays and cost increases, the company expects additional expenses and lower profitability.
As a result, Mitsubishi Chemical anticipates reporting approximately ¥30.00 billion in impairment losses for the fiscal year ending March 2026. This impact was not included in the previously disclosed earnings forecast on February 5, 2026. The revised investment plan includes increased costs due to complex contract management and higher material and labor expenses amid global inflation. Despite these challenges, Mitsubishi Chemical remains committed to its sustainability goals through innovations like Soarnol™, which supports food quality preservation and reduces waste.
Mitsubishi Chemical UK Limited operates out of Soarnol House in Hull, UK, focusing on chemical manufacturing. With a capital of ¥23,209 thousand euros, the subsidiary plays a crucial role in the group’s chemicals division growth strategy. The new production facility is scheduled to commence operations in fiscal 2027. Separately, the company noted that the divestiture of shares and related assets of Mitsubishi Pharma Corporation, completed on July 1, 2025, affects the reported figures for the fiscal year ended March 2025.
Mitsubishi Pharma changed its name to December 01, 2025 to Nippon Shinyaku Co., Ltd.
🟡 Confidence: Standard AI-translated content.